Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Givinostat in Ambulant Children With Duchenne Muscular Dystrophy
NCT01761292Phase 2Completed
- Sponsor
- Italfarmaco
- Start
- Apr 2013
- Primary completion
- Dec 2014
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of givinostat in Duchenne muscular dystrophy (DMD), sponsored by Italfarmaco. Started Apr 2013; status: completed.
02
Drugs
givinostat
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT01761292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01761292.